This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

As an antiarrhythmic

Authoring team

Lignocaine is indicated in ventricular arrhythmias, particularly after mycocardial infarction. It is a drug with a large volume of distribution and thus there is a high loading dose and relatively small maintenance dose. It is broken down in the liver.

Cautions include congestive cardiac failure, hepatic failure, and cardiac surgery.

Contraindications include sino-atrial disorders, atrioventricluar block, myocardial depression and porphyria.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.